These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29735159)

  • 1. Characteristics of adult patients treated for acute myeloid leukemia with inv 16 in Casablanca (Morocco).
    Houssou B; Lamchahab M; Massi R; Oukkache B; Quessar A
    Bull Cancer; 2018 Jun; 105(6):552-555. PubMed ID: 29735159
    [No Abstract]   [Full Text] [Related]  

  • 2. A case with a cytogenetically cryptic variant of the inv(16)(p13q22)/t(16;16)(p13;q22).
    Van Obbergh F; Michaux L; Maertens J; Schoemans H; Vandenberghe P
    Cancer Genet; 2014 May; 207(5):231-2. PubMed ID: 24972931
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging therapies for inv(16) AML.
    Surapally S; Tenen DG; Pulikkan JA
    Blood; 2021 May; 137(19):2579-2584. PubMed ID: 33821975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
    Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
    Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetically masked
    Ducourneau B; Fenwarth L; Duployez N; Lambert J; Struski S; Luquet I; Daudignon A; Helevaut N; Ruminy P; Preudhomme C; Terre C
    Leuk Lymphoma; 2020 Jul; 61(7):1772-1774. PubMed ID: 32223488
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of leukemia progression in the Cbfb-MYH11 knockin mice by single cell RNA sequencing.
    Diemer JL; Yu K; Kelly M; Zhen T; Anderson S; Lopez G; Liu P
    Leukemia; 2023 Jul; 37(7):1549-1553. PubMed ID: 37225965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
    Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
    Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
    Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of 3'CBFbeta in an inv(16)(p13.lq22) ascertained by fluorescence in situ hybridization and reverse-transcriptase polymerase chain reaction.
    Hung D; St Heaps L; Benson W; Mirochnik O; Sharma P; Smith A
    Cancer Genet Cytogenet; 2007 Jan; 172(1):92-4. PubMed ID: 17175390
    [No Abstract]   [Full Text] [Related]  

  • 12. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia.
    Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
    Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
    Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
    Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22).
    Kanaya M; Kondo T
    Int J Hematol; 2020 Aug; 112(2):134-135. PubMed ID: 32506319
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
    Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
    Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental identification of inv(16)(p13.1q22)/
    Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
    Eghtedar A; Borthakur G; Ravandi F; Jabbour E; Cortes J; Pierce S; Kantarjian H; Garcia-Manero G
    Am J Hematol; 2012 Mar; 87(3):317-8. PubMed ID: 22228403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.